CoChat

B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice

Open access

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Abstract

The germinal center (GC) is a site where somatic hypermutation and clonal selection are coupled for antibody affinity maturation against infections. However, how GCs are formed and regulated is incompletely understood. Here, we identified an unexpected role of Tank-binding kinase-1 (TBK1) as a crucial B cell–intrinsic factor for GC formation. Using immunization and malaria infection models, we show that TBK1-deficient B cells failed to form GC despite normal Tfh cell differentiation, although some malaria-infected B cell–specific TBK1-deficient mice could survive by GC-independent mechanisms. Mechanistically, TBK1 phosphorylation elevates in B cells during GC differentiation and regulates the balance of IRF4/BCL6 expression by limiting CD40 and BCR activation through noncanonical NF-κB and AKTT308 signaling. In the absence of TBK1, CD40 and BCR signaling synergistically enhanced IRF4 expression in Pre-GC, leading to BCL6 suppression, and therefore failed to form GCs. As a result, memory B cells generated from TBK1-deficient B cells fail to confer sterile immunity upon reinfection, suggesting that TBK1 determines B cell fate to promote long-lasting humoral immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20211336

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY-NC-SA · PubMed Central
Figure S1. Tfh cells and GC formation are essential for recovery from PyNL infection. (A) Parasitemia of WT mice infected with PyNL. n = 24 mice pooled from four independent experiments. (B) Time-course analysis of Tfh cells and GC formation in the spleens of WT mice infected with PyNL. n = 4–5 mice per time point from four independent experiments. (C and D) Representative FACS plots of Tfh (C) and GC (D) populations in the spleens of Cd4creBcl6f/f (Tfh−/−) mice and Cd4wtBcl6f/f (Tfh+/+) mice infected with PyNL. n = 4 mice/group representative of two independent experiments. (E) Parasitemia and survival of Tfh−/− mice and Tfh+/+ mice infected with PyNL. n = 9–10 mice/group pooled from two independent experiments. Each dot represents data from an individual mouse. Data are pooled from four independent experiments (A and B) or representative of two independent experiments (C and D). Data are shown as mean ± SD. **, P < 0.01; ***, P < 0.001; Mann-Whitney t test (E), log-rank (Mantel-Cox) test (E).
Figure S1. Tfh cells and GC formation are essential for recovery from PyNL infection. (A) Parasitemia of WT mice infected with PyNL. n = 24 mice pooled from four independent experiments. (B) Time-course analysis of Tfh cells and GC formation in the spleens of WT mice infected with PyNL. n = 4–5 mice per time point from four independent experiments. (C and D) Representative FACS plots of Tfh (C) and GC (D) populations in the spleens of Cd4creBcl6f/f (Tfh−/−) mice and Cd4wtBcl6f/f (Tfh+/+) mice infected with PyNL. n = 4 mice/group representative of two independent experiments. (E) Parasitemia and survival of Tfh−/− mice and Tfh+/+ mice infected with PyNL. n = 9–10 mice/group pooled from two independent experiments. Each dot represents data from an individual mouse. Data are pooled from four independent experiments (A and B) or representative of two independent experiments (C and D). Data are shown as mean ± SD. **, P < 0.01; ***, P < 0.001; Mann-Whitney t test (E), log-rank (Mantel-Cox) test (E).CC BY-NC-SA · PubMed Central
Figure 1. TBK1 is involved in GC B cell differentiation. (A) Protein expression and phosphorylation of TBK1 in purified naive B cells from naive mice, Pre-GC B cells from day 9 PyNL-infected mice, and GC B cells from day 30 PyNL-infected mice, pooled from two mice per group. Graph shows the quantitative band intensity normalized to actin control or total TBK1 protein. (B) Representative FACS analysis of GC B cell population in the spleen on day 24 after PyNL infection. Plots are gated on CD19+ IgD− cells. (C) Proportions and cell numbers of the GC B cell population in the spleen of PyNL-infected mice over time. n = 4–6 mice/group at each time point from day 0 to day 24; n = 2–6 mice/group at day 35. (D) Immunohistochemical analysis of spleens from B Tbk1−/− and B Tbk1+/+ mice that recovered from PyNL infection on day 35 after infection. Staining of CD4 (blue), expressed in CD4 T cells; IgD (red), expressed in mature follicular B cells; GL7 (green), expressed in the GC. Scale bars, 1 mm. (E) Survival of B Tbk1−/− and B Tbk1+/+ mice upon PyNL infection. n = 11–14 mice/group. (F) Parasitemia of B Tbk1−/− mice that died, n = 8; B Tbk1−/− mice that survived, n = 6; and B Tbk1+/+ mice, n = 11; after infection with PyNL. †, time point of death. (G) Representative FACS plots and percentages of splenic GC B cell population among total B cells 14 d and 21 d after immunization with NIP-OVA with alum adjuvant. n = 5–7 mice/group. (H) Immunohistochemical analysis of spleens from B Tbk1−/− and B Tbk1+/+ mice 21 d after immunization. Scale bars, 200 µm. Each dot represents an individual mouse. Data are representative of two (A) or three (G) independent experiments and pooled from five (C) or three (E and F) independent experiments, representative of at least two (D) or three (H) biological replicates. Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001; unpaired Student’s t test (C), Mann-Whitney t test (G), or log-rank (Mantel-Cox) test (E). Source data are available for this figure: SourceData F1.
Figure 1. TBK1 is involved in GC B cell differentiation. (A) Protein expression and phosphorylation of TBK1 in purified naive B cells from naive mice, Pre-GC B cells from day 9 PyNL-infected mice, and GC B cells from day 30 PyNL-infected mice, pooled from two mice per group. Graph shows the quantitative band intensity normalized to actin control or total TBK1 protein. (B) Representative FACS analysis of GC B cell population in the spleen on day 24 after PyNL infection. Plots are gated on CD19+ IgD− cells. (C) Proportions and cell numbers of the GC B cell population in the spleen of PyNL-infected mice over time. n = 4–6 mice/group at each time point from day 0 to day 24; n = 2–6 mice/group at day 35. (D) Immunohistochemical analysis of spleens from B Tbk1−/− and B Tbk1+/+ mice that recovered from PyNL infection on day 35 after infection. Staining of CD4 (blue), expressed in CD4 T cells; IgD (red), expressed in mature follicular B cells; GL7 (green), expressed in the GC. Scale bars, 1 mm. (E) Survival of B Tbk1−/− and B Tbk1+/+ mice upon PyNL infection. n = 11–14 mice/group. (F) Parasitemia of B Tbk1−/− mice that died, n = 8; B Tbk1−/− mice that survived, n = 6; and B Tbk1+/+ mice, n = 11; after infection with PyNL. †, time point of death. (G) Representative FACS plots and percentages of splenic GC B cell population among total B cells 14 d and 21 d after immunization with NIP-OVA with alum adjuvant. n = 5–7 mice/group. (H) Immunohistochemical analysis of spleens from B Tbk1−/− and B Tbk1+/+ mice 21 d after immunization. Scale bars, 200 µm. Each dot represents an individual mouse. Data are representative of two (A) or three (G) independent experiments and pooled from five (C) or three (E and F) independent experiments, representative of at least two (D) or three (H) biological replicates. Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001; unpaired Student’s t test (C), Mann-Whitney t test (G), or log-rank (Mantel-Cox) test (E). Source data are available for this figure: SourceData F1.CC BY-NC-SA · PubMed Central
Figure S2. TBK1 expression in B cell and deletion efficiency in B cells and T cells using a Cre-loxP system. (A) Expression and phosphorylation of TBK1 in human B cells from PBMCs and mouse splenic B cells by immunoblotting. (B) Depletion efficiency of TBK1 in splenic B cells was analyzed by immunoblotting. (C) Analysis of subpopulations of B cells in spleen, peritoneum, and bone marrow isolated from B Tbk1−/− and B Tbk1+/+ mice by flow cytometry. FSC-A, forward scatter area. (D) Immunohistochemical staining of B cell zone (red; IgD) and T cell zone (blue; CD4) in the spleens of B Tbk1−/− and B Tbk1+/+ mice. Data are representative of two (A) or five (B) independent experiments or from one experiment with a representative of three independent biological samples (C and D). Scale bars, 500 µm. Source data are available for this figure: SourceData FS2.
Figure S2. TBK1 expression in B cell and deletion efficiency in B cells and T cells using a Cre-loxP system. (A) Expression and phosphorylation of TBK1 in human B cells from PBMCs and mouse splenic B cells by immunoblotting. (B) Depletion efficiency of TBK1 in splenic B cells was analyzed by immunoblotting. (C) Analysis of subpopulations of B cells in spleen, peritoneum, and bone marrow isolated from B Tbk1−/− and B Tbk1+/+ mice by flow cytometry. FSC-A, forward scatter area. (D) Immunohistochemical staining of B cell zone (red; IgD) and T cell zone (blue; CD4) in the spleens of B Tbk1−/− and B Tbk1+/+ mice. Data are representative of two (A) or five (B) independent experiments or from one experiment with a representative of three independent biological samples (C and D). Scale bars, 500 µm. Source data are available for this figure: SourceData FS2.CC BY-NC-SA · PubMed Central
Figure S3. B Tbk1−/− mice could produce antigen-specific antibodies, albeit less of them, despite the lack of GC formation. (A) PyNL-specific serum antibody measurement by ELISA on days 28–35 after infection with PyNL. n = 6–10 mice/group from three independent experiments. (B) Avidity assay of PyNL-specific serum antibody on days 19–35 after infection with PyNL. n = 10–12 mice/group from five independent experiments. (C) NP30 (4-hydroxy-3-nitrophenylacetyl hapten conjugated BSA ratio 30)-specific serum antibody measurement by ELISA on day 21 after immunization with NIP-OVA with alum i.d. n = 6–7 mice/group representative of two independent experiments. (D) ASC population in the spleens of PyNL-infected mice on day 24 analyzed by FACS. n = 4–5 mice/group representative of two independent experiments. Each dot represents data from an individual mouse. Data are pooled from three (A) or five (B) independent experiments and representative of two independent experiments (C and D). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001; Mann-Whitney t test (A–D).
Figure S3. B Tbk1−/− mice could produce antigen-specific antibodies, albeit less of them, despite the lack of GC formation. (A) PyNL-specific serum antibody measurement by ELISA on days 28–35 after infection with PyNL. n = 6–10 mice/group from three independent experiments. (B) Avidity assay of PyNL-specific serum antibody on days 19–35 after infection with PyNL. n = 10–12 mice/group from five independent experiments. (C) NP30 (4-hydroxy-3-nitrophenylacetyl hapten conjugated BSA ratio 30)-specific serum antibody measurement by ELISA on day 21 after immunization with NIP-OVA with alum i.d. n = 6–7 mice/group representative of two independent experiments. (D) ASC population in the spleens of PyNL-infected mice on day 24 analyzed by FACS. n = 4–5 mice/group representative of two independent experiments. Each dot represents data from an individual mouse. Data are pooled from three (A) or five (B) independent experiments and representative of two independent experiments (C and D). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001; Mann-Whitney t test (A–D).CC BY-NC-SA · PubMed Central
Figure 2. TBK1-deficient B cells drive Tfh cell differentiation despite the lack of GC B cells. (A) Time-course analysis of Tfh cell proportions and cell numbers in the spleens of B Tbk1−/− and B Tbk1+/+ mice infected with PyNL analyzed by FACS. n = 4–6 mice/group. (B) Representative FACS plots and histograms of BCL6, IL-21, and ICOS expression in naive T cells (TCRβ+ CD4+ PD1− CXCR5−), activated T cells (TCRβ+ CD4+ PD1+ CXCR5−), pre-Tfh cells (TCRβ+ CD4+ PD1+ CXCR5lo), and mature Tfh cells (TCRβ+ CD4+ PD1+ CXCR5hi) in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 22 after infection with PyNL. (C) Mean fluorescence intensity (MFI) of BCL6, IL-21, and ICOS expression in subsets of T cells in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 24 after infection with PyNL. n = 4–5 mice/group from two independent experiments. (D) Tfr population in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 24 after infection with PyNL. n = 4–5 mice/group. (E) MFI of ICOSL, CD86, CD40, and CD80 expression on B cells on day 24 after infection with PyNL. n = 4–6 mice/group. (F) Tfh cell population and ICOS expression on Tfh cells in the dLN on day 12 after immunization with NIP-OVA and alum. n = 5 mice/group. (G–I) Mixed bone marrow (BM) chimeric mice were immunized with NIP-OVA and alum. Schematic diagram of the experimental protocol (G), flow cytometry gating strategy (H), flow cytometry analysis of CD45.1− B Tbk1−/− B cells and CD45.1+ WT B cells (I). n = 5 mice. Representative of two independent experiments. Each dot represents an individual mouse. Data are from four experiments (A) or are representative of two experiments (B–I). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; Mann-Whitney t test (A, C–F, and I).
Figure 2. TBK1-deficient B cells drive Tfh cell differentiation despite the lack of GC B cells. (A) Time-course analysis of Tfh cell proportions and cell numbers in the spleens of B Tbk1−/− and B Tbk1+/+ mice infected with PyNL analyzed by FACS. n = 4–6 mice/group. (B) Representative FACS plots and histograms of BCL6, IL-21, and ICOS expression in naive T cells (TCRβ+ CD4+ PD1− CXCR5−), activated T cells (TCRβ+ CD4+ PD1+ CXCR5−), pre-Tfh cells (TCRβ+ CD4+ PD1+ CXCR5lo), and mature Tfh cells (TCRβ+ CD4+ PD1+ CXCR5hi) in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 22 after infection with PyNL. (C) Mean fluorescence intensity (MFI) of BCL6, IL-21, and ICOS expression in subsets of T cells in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 24 after infection with PyNL. n = 4–5 mice/group from two independent experiments. (D) Tfr population in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 24 after infection with PyNL. n = 4–5 mice/group. (E) MFI of ICOSL, CD86, CD40, and CD80 expression on B cells on day 24 after infection with PyNL. n = 4–6 mice/group. (F) Tfh cell population and ICOS expression on Tfh cells in the dLN on day 12 after immunization with NIP-OVA and alum. n = 5 mice/group. (G–I) Mixed bone marrow (BM) chimeric mice were immunized with NIP-OVA and alum. Schematic diagram of the experimental protocol (G), flow cytometry gating strategy (H), flow cytometry analysis of CD45.1− B Tbk1−/− B cells and CD45.1+ WT B cells (I). n = 5 mice. Representative of two independent experiments. Each dot represents an individual mouse. Data are from four experiments (A) or are representative of two experiments (B–I). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; Mann-Whitney t test (A, C–F, and I).CC BY-NC-SA · PubMed Central
Figure 3. CD4+ T cell–intrinsic TBK1 is dispensable for Tfh cell maturation. (A) Depletion efficiency of Tbk1 in splenic CD4+ T cells of Cd4cre Tbk1f/f mice (T Tbk1−/−) and Cd4wt Tbk1f/f mice (T Tbk1+/+) was analyzed by immunoblotting. B cells from WT mice were used as a control. (B) Population of Tfh cells in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 24 after infection with PyNL analyzed by FACS. n = 4–5 mice/group. (C) Representative FACS plots and histograms of BCL6, IL-21, and ICOS expression in naive T cells, activated T cells, pre-Tfh cells, and mature Tfh cells in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 24 after infection with PyNL. n = 4–5 mice/group. MFI, mean fluorescence intensity. (D) Population of Tfh cells in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 12 after immunization with NIP-OVA with alum. n = 5 mice/group. (E) GC population in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 24 after infection with PyNL. n = 4–5 mice/group. (F) GC population in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 12 after immunization with NIP-OVA with alum. N = 5 mice/group. Each dot represents an individual mouse. Data are representative of two independent experiments (A–F). Data are shown as mean ± SD. Mann-Whitney t test (B–F). Source data are available for this figure: SourceData F3.
Figure 3. CD4+ T cell–intrinsic TBK1 is dispensable for Tfh cell maturation. (A) Depletion efficiency of Tbk1 in splenic CD4+ T cells of Cd4cre Tbk1f/f mice (T Tbk1−/−) and Cd4wt Tbk1f/f mice (T Tbk1+/+) was analyzed by immunoblotting. B cells from WT mice were used as a control. (B) Population of Tfh cells in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 24 after infection with PyNL analyzed by FACS. n = 4–5 mice/group. (C) Representative FACS plots and histograms of BCL6, IL-21, and ICOS expression in naive T cells, activated T cells, pre-Tfh cells, and mature Tfh cells in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 24 after infection with PyNL. n = 4–5 mice/group. MFI, mean fluorescence intensity. (D) Population of Tfh cells in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 12 after immunization with NIP-OVA with alum. n = 5 mice/group. (E) GC population in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 24 after infection with PyNL. n = 4–5 mice/group. (F) GC population in the spleens of T Tbk1−/− and T Tbk1+/+ mice on day 12 after immunization with NIP-OVA with alum. N = 5 mice/group. Each dot represents an individual mouse. Data are representative of two independent experiments (A–F). Data are shown as mean ± SD. Mann-Whitney t test (B–F). Source data are available for this figure: SourceData F3.CC BY-NC-SA · PubMed Central
Figure 4. TBK1 deficiency alters the gene expression in Pre-GC. (A) Representative histograms and expansion index of CTV-stained splenic B cells of day 9 PyNL-infected B Tbk1−/− and B Tbk1+/+ mice stimulated with anti-CD40, anti-IgM, or anti-CD40+ anti-IgM for 4 d analyzed by FACS. n = 4–5 mice/group. (B) Population and cell number of CD38+ GL7+ Pre-GC cells gated from CD19+ B220+ IgD− population in the spleen of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL analyzed by FACS. n = 4–6 mice/group. (C) IgG1 class switching of Pre-GC of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL. n = 4–6 mice/group. (D) Cell cycle analysis of Pre-GC on day 9 after infection with PyNL. n = 4–5 mice/group. (E) Apoptotic cell death analysis of Pre-GC on day 9 after infection with PyNL. n = 4–5 mice/group. (F) Pre-GC isolated from day 9 after infection with PyNL analyzed by RNA-seq. n = 4 mice/group. Gene sets enriched for DEGs between B Tbk1−/− Pre-GC and B Tbk1+/+ Pre-GC analyzed by GSEA using gene signatures from MSigDB Hallmark (false discovery rate [FDR] q value <0.25%; P < 0.05). NES, normalized enrichment score. (G) Volcano plot of DEGs (1.33-fold; P < 0.05) between B Tbk1−/− Pre-GC and B Tbk1+/+ Pre-GC isolated from day 9 after infection with PyNL analyzed by RNA-seq. n = 4 mice/group. (H) Gene expression of Irf4, myc, Nfkbid, and Nfkbia presented as fragments per kilobase of exon per million reads mapped (FPKM) values in RNA-seq of B Tbk1−/− Pre-GC and B Tbk1+/+ Pre-GC. (I) Enrichment of genes up-regulated by CD40 and BCR and expressed in c-Myc+ B cells in B Tbk1−/− Pre-GC compared with B Tbk1+/+ Pre-GC analyzed by GSEA. NES, normalized enrichment score. Each dot represents data from an individual mouse. Data are representative of two (A and C–E) or three independent experiments (B) or from one experiment (F–I). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; Mann-Whitney t test (A–E and H). AAD, SYTOX AADvanced.
Figure 4. TBK1 deficiency alters the gene expression in Pre-GC. (A) Representative histograms and expansion index of CTV-stained splenic B cells of day 9 PyNL-infected B Tbk1−/− and B Tbk1+/+ mice stimulated with anti-CD40, anti-IgM, or anti-CD40+ anti-IgM for 4 d analyzed by FACS. n = 4–5 mice/group. (B) Population and cell number of CD38+ GL7+ Pre-GC cells gated from CD19+ B220+ IgD− population in the spleen of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL analyzed by FACS. n = 4–6 mice/group. (C) IgG1 class switching of Pre-GC of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL. n = 4–6 mice/group. (D) Cell cycle analysis of Pre-GC on day 9 after infection with PyNL. n = 4–5 mice/group. (E) Apoptotic cell death analysis of Pre-GC on day 9 after infection with PyNL. n = 4–5 mice/group. (F) Pre-GC isolated from day 9 after infection with PyNL analyzed by RNA-seq. n = 4 mice/group. Gene sets enriched for DEGs between B Tbk1−/− Pre-GC and B Tbk1+/+ Pre-GC analyzed by GSEA using gene signatures from MSigDB Hallmark (false discovery rate [FDR] q value <0.25%; P < 0.05). NES, normalized enrichment score. (G) Volcano plot of DEGs (1.33-fold; P < 0.05) between B Tbk1−/− Pre-GC and B Tbk1+/+ Pre-GC isolated from day 9 after infection with PyNL analyzed by RNA-seq. n = 4 mice/group. (H) Gene expression of Irf4, myc, Nfkbid, and Nfkbia presented as fragments per kilobase of exon per million reads mapped (FPKM) values in RNA-seq of B Tbk1−/− Pre-GC and B Tbk1+/+ Pre-GC. (I) Enrichment of genes up-regulated by CD40 and BCR and expressed in c-Myc+ B cells in B Tbk1−/− Pre-GC compared with B Tbk1+/+ Pre-GC analyzed by GSEA. NES, normalized enrichment score. Each dot represents data from an individual mouse. Data are representative of two (A and C–E) or three independent experiments (B) or from one experiment (F–I). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; Mann-Whitney t test (A–E and H). AAD, SYTOX AADvanced.CC BY-NC-SA · PubMed Central
Figure S4. TBK1 negatively regulates CD40 and BCR signaling. (A) Heatmap of GO biological process pathway analysis by GSEA (preranked fast GSEA) based on RNA-seq analysis. (B) TBK1-dependent genes up-regulated by CD40 or BCR stimulation in Pre-GC analyzed by GSEA based on RNA-seq data (related to Fig. 4 I). Data are from one experiment. n = 4 mice/group. NES, normalized enrichment score.
Figure S4. TBK1 negatively regulates CD40 and BCR signaling. (A) Heatmap of GO biological process pathway analysis by GSEA (preranked fast GSEA) based on RNA-seq analysis. (B) TBK1-dependent genes up-regulated by CD40 or BCR stimulation in Pre-GC analyzed by GSEA based on RNA-seq data (related to Fig. 4 I). Data are from one experiment. n = 4 mice/group. NES, normalized enrichment score.CC BY-NC-SA · PubMed Central
Figure 5. TBK1 negatively regulates IRF4 by limiting CD40 signaling in Pre-GC. (A and B) Representative histograms (A) and mean fluorescence intensity (MFI) of IRF4 and BCL6 expression (B) in GL7− B cells and GL7+ Pre-GC of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL analyzed by FACS. FMO, fluorescence minus one control. n = 4–5 mice/group. (C) Representative FACS plots and proportion of IRF4+ Pre-GC and BCL6+ Pre-GC populations in the spleen of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL. n = 4–5 mice/group. (D) Ratio of BCL6+ Pre-GC and IRF4+ Pre-GC populations in the spleen on day 9 after infection with PyNL. n = 4–5 mice/group, representative of two independent experiments. (E) Time-course analysis of BCL6+ B cell population during PyNL infection. n = 4–6 mice/group. (F) Population of ASCs in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL. n = 4–5 mice/group. (G) IRF4 expression in WT naive B cells stimulated for 16 h with 10 µg/ml anti-CD40 and/or with anti-IgM analyzed by FACS. n = 3 mice. (H) RelB and p52 expression in splenic GL7+ Pre-GC (CD19+ B220+ GL7+) of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL. N = 4 mice/group. (I) Immunoblot analysis of the time course of in vitro stimulation of naive B cells from B Tbk1−/− and B Tbk1+/+ mice with 1 μg/ml anti-CD40. Each dot represents data from an individual mouse. Data are representative of two independent experiments (A–D and F–I) or from three independent experiments (E). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; Mann-Whitney t test (B–F and H) or unpaired Student’s t test (G). Source data are available for this figure: SourceData F5.
Figure 5. TBK1 negatively regulates IRF4 by limiting CD40 signaling in Pre-GC. (A and B) Representative histograms (A) and mean fluorescence intensity (MFI) of IRF4 and BCL6 expression (B) in GL7− B cells and GL7+ Pre-GC of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL analyzed by FACS. FMO, fluorescence minus one control. n = 4–5 mice/group. (C) Representative FACS plots and proportion of IRF4+ Pre-GC and BCL6+ Pre-GC populations in the spleen of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL. n = 4–5 mice/group. (D) Ratio of BCL6+ Pre-GC and IRF4+ Pre-GC populations in the spleen on day 9 after infection with PyNL. n = 4–5 mice/group, representative of two independent experiments. (E) Time-course analysis of BCL6+ B cell population during PyNL infection. n = 4–6 mice/group. (F) Population of ASCs in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL. n = 4–5 mice/group. (G) IRF4 expression in WT naive B cells stimulated for 16 h with 10 µg/ml anti-CD40 and/or with anti-IgM analyzed by FACS. n = 3 mice. (H) RelB and p52 expression in splenic GL7+ Pre-GC (CD19+ B220+ GL7+) of B Tbk1−/− and B Tbk1+/+ mice on day 9 after infection with PyNL. N = 4 mice/group. (I) Immunoblot analysis of the time course of in vitro stimulation of naive B cells from B Tbk1−/− and B Tbk1+/+ mice with 1 μg/ml anti-CD40. Each dot represents data from an individual mouse. Data are representative of two independent experiments (A–D and F–I) or from three independent experiments (E). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; Mann-Whitney t test (B–F and H) or unpaired Student’s t test (G). Source data are available for this figure: SourceData F5.CC BY-NC-SA · PubMed Central
Figure S5. TBK1 negatively regulates CD40-induced noncanonical NF-κB signaling in B cells. Time-course analysis of cytosolic and nuclear fractions of Tbk1−/− and B Tbk1+/+ naive B cells stimulated with 1 µg/ml anti-CD40 and analyzed by immunoblotting. Representative of two independent experiments. Source data are available for this figure: SourceData FS5.
Figure S5. TBK1 negatively regulates CD40-induced noncanonical NF-κB signaling in B cells. Time-course analysis of cytosolic and nuclear fractions of Tbk1−/− and B Tbk1+/+ naive B cells stimulated with 1 µg/ml anti-CD40 and analyzed by immunoblotting. Representative of two independent experiments. Source data are available for this figure: SourceData FS5.CC BY-NC-SA · PubMed Central
Figure 6. TBK1 is a limiting factor that fine tunes CD40 and BCR signaling in Pre-GC. (A) Schematic diagram of ex vivo splenic B cells isolated from day 9 PyNL-infected B Tbk1−/− and B Tbk1+/+ mice with CD40 and/or BCR stimulation for the evaluation of IRF4 and c-Myc expression on gated B220+ GL7+ Pre-GC and B220+ GL7− non–Pre-GC B cell population by FACS. (B and C) Representative histograms and graphs showing IRF4 expression (B) and c-Myc expression (C) of GL7+ Pre-GC and GL7− non–Pre-GC upon CD40 and/or BCR stimulation. n = 4 mice/group. (D) Representative histograms and graph showing AKT phosphorylation at S473 and T308 on Pre-GC cells on day 9 after infection with PyNL. n = 4 mice/group. Each dot represents data from an individual mouse. Data are representative of two independent experiments (A–D). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001; one-way ANOVA (B and C), Mann-Whitney t test (D). gMFI, geometric mean fluorescence intensity.
Figure 6. TBK1 is a limiting factor that fine tunes CD40 and BCR signaling in Pre-GC. (A) Schematic diagram of ex vivo splenic B cells isolated from day 9 PyNL-infected B Tbk1−/− and B Tbk1+/+ mice with CD40 and/or BCR stimulation for the evaluation of IRF4 and c-Myc expression on gated B220+ GL7+ Pre-GC and B220+ GL7− non–Pre-GC B cell population by FACS. (B and C) Representative histograms and graphs showing IRF4 expression (B) and c-Myc expression (C) of GL7+ Pre-GC and GL7− non–Pre-GC upon CD40 and/or BCR stimulation. n = 4 mice/group. (D) Representative histograms and graph showing AKT phosphorylation at S473 and T308 on Pre-GC cells on day 9 after infection with PyNL. n = 4 mice/group. Each dot represents data from an individual mouse. Data are representative of two independent experiments (A–D). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001; one-way ANOVA (B and C), Mann-Whitney t test (D). gMFI, geometric mean fluorescence intensity.CC BY-NC-SA · PubMed Central
Figure 7. B cell–intrinsic TBK1 deficiency impairs immunity to reinfection. (A) Schematic diagram of PyNL infection, treatment, and reinfection for the evaluation of memory B cells. iRBC, PyNL-infected erythrocytes. (B) Giemsa-stained blood smears of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection. Scale bar, 200 mm. (C) Population of GC B cells in the spleen of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection analyzed by FACS. (D) Expression of CD73 on IgG1+ or IgG2c+ memory B cells (CD19+ IgD− CD138− CD38+) of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection analyzed by flow cytometry. MFI, mean fluorescence intensity. (E) Population of IgG1+ and IgG2c+ GC B cells in the spleens of B Tbk1+/+ mice on day 6 after challenge with PyNL infection. (F) Population of IgG1+ memory B cells in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection. (G) Serum antibody levels of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection. Each dot represents data from an individual mouse. n = 5–6 mice/group. Data are representative of two independent experiments (A–G). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; Mann-Whitney t test (A–G).
Figure 7. B cell–intrinsic TBK1 deficiency impairs immunity to reinfection. (A) Schematic diagram of PyNL infection, treatment, and reinfection for the evaluation of memory B cells. iRBC, PyNL-infected erythrocytes. (B) Giemsa-stained blood smears of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection. Scale bar, 200 mm. (C) Population of GC B cells in the spleen of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection analyzed by FACS. (D) Expression of CD73 on IgG1+ or IgG2c+ memory B cells (CD19+ IgD− CD138− CD38+) of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection analyzed by flow cytometry. MFI, mean fluorescence intensity. (E) Population of IgG1+ and IgG2c+ GC B cells in the spleens of B Tbk1+/+ mice on day 6 after challenge with PyNL infection. (F) Population of IgG1+ memory B cells in the spleens of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection. (G) Serum antibody levels of B Tbk1−/− and B Tbk1+/+ mice on day 6 after challenge with PyNL infection. Each dot represents data from an individual mouse. n = 5–6 mice/group. Data are representative of two independent experiments (A–G). Data are shown as mean ± SD. *, P < 0.05; **, P < 0.01; Mann-Whitney t test (A–G).CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 88 references

Cited by

See all 21

Metadata

Authors
Lee, M. S. J., Inoue, T., Ise, W., Matsuo-Dapaah, J., Wing, J. B., Temizoz, B., Kobiyama, K., Hayashi, T., Patil, A., Sakaguchi, S., Simon, A. K., Bezbradica, J. S., Nagatoishi, S., Tsumoto, K., Inoue, J.-I., Akira, S., Kurosaki, T., Ishii, K. J., & Coban, C.
Affiliations
  • Institute of Medical Science, The University of Tokyo (JP)
  • Immunology Frontier Research Center, The University of Osaka (JP)
  • Center for Infectious Disease Education and Research, The University of Osaka (JP)
  • Combinatics Inc., Tokyo, Japan 6
  • University of Oxford (GB)
Corresponding author
  • Ishii, Ken J.
  • Coban, Cevayir
Venue
Journal of Experimental Medicine
Published
2021-12-15
Volume
219
Issue
2
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W4200054170
Cited by
21
References
87
Citations by year
2026: 2 · 2025: 8 · 2024: 1 · 2023: 5 · 2022: 5
FWCI
1.03
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
Funders
  • Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development (17fm0208021h0001)
  • International Joint Research Project
  • Mitsubishi UFJ
  • Institute of Medical Science, University of Tokyo
  • Japan Society for the Promotion of Science (JP19K16833, JP 20K16234)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
TBK1, germinal center formation, B cells, IRF4, BCL6, CD40 signaling, B cell receptor signaling, non-canonical NF-κB signaling, T follicular helper cells, somatic hypermutation, affinity maturation, malaria, vaccination, memory B cells, humoral immunity, sterile immunity
MeSH terms
Animals, B-Lymphocytes, Gene Expression Regulation, T-Lymphocytes, Helper-Inducer, Immunization, Infections, Receptors, Antigen, B-Cell, Signal Transduction, Biomarkers, Protein Serine-Threonine Kinases, Germinal Center, CD40 Antigens, Mice, Host-Pathogen Interactions, Gene Knockdown Techniques, Immunity, Humoral

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice. https://app.cochat.ai/papers/10.1084/jem.20211336
The paper
Lee, M. S. J., Inoue, T., Ise, W., Matsuo-Dapaah, J., Wing, J. B., Temizoz, B., Kobiyama, K., Hayashi, T., Patil, A., Sakaguchi, S., Simon, A. K., Bezbradica, J. S., Nagatoishi, S., Tsumoto, K., Inoue, J.-I., Akira, S., Kurosaki, T., Ishii, K. J., & Coban, C. (2022). B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20211336

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.